Webinar0.5 CE Credits
Re-Evaluating the Role of Radiopharmaceuticals in the Management of mCRPC: How Should Recent Data Inform Individualized Treatment? - Webinar 1
Hosted by PeerVoice
May 25, 2026 Online / Virtual
About This Event
A data-focused webinar session featuring expert faculty who will summarize and discuss recent novel data on combination approaches using radiopharmaceutical agents for metastatic castration-resistant prostate cancer (mCRPC). The session includes plenary presentations of pertinent congress data followed by collaborative faculty discussion and audience Q&A on implications for clinical practice.
Registration & Fees
Continuing Education
0.5 CE Credits
Accredited by: AMA
AMA PRA Category 1 Credit